Wellington Management Group
UTHR icon

Wellington Management Group’s United Therapeutics UTHR Stock Holding History

Wellington Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$747M Sell
1,379,025
-885,222
-39% -$499M 0.13% 167
2026
Q1 		$1.34B Sell
2,264,247
-177,245
-7% -$88.3M 0.25% 93
2025
Q4 		$1.19B Buy
2,441,492
+1,042,711
+75% +$486M 0.21% 109
2025
Q3 		$586M Sell
1,398,781
-44,155
-3% -$14.8M 0.1% 186
2025
Q2 		$415M Sell
1,442,936
-583,480
-29% -$174M 0.08% 220
2025
Q1 		$625M Sell
2,026,416
-437,475
-18% -$150M 0.12% 163
2024
Q4 		$869M Sell
2,463,891
-706,958
-22% -$260M 0.16% 137
2024
Q3 		$1.14B Sell
3,170,849
-114,440
-3% -$38.7M 0.2% 122
2024
Q2 		$1.05B Sell
3,285,289
-126,971
-4% -$33.6M 0.19% 130
2024
Q1 		$784M Sell
3,412,260
-381,750
-10% -$86.1M 0.14% 163
2023
Q4 		$834M Sell
3,794,010
-327,803
-8% -$75.6M 0.16% 150
2023
Q3 		$931M Sell
4,121,813
-567,011
-12% -$131M 0.19% 125
2023
Q2 		$1.04B Buy
4,688,824
+906,984
+24% +$201M 0.2% 121
2023
Q1 		$847M Buy
3,781,840
+1,212,577
+47% +$299M 0.17% 135
2022
Q4 		$714M Buy
2,569,263
+1,212,497
+89% +$306M 0.14% 154
2022
Q3 		$284M Sell
1,356,766
-97,291
-7% -$21.8M 0.06% 284
2022
Q2 		$343M Sell
1,454,057
-221,357
-13% -$45M 0.07% 253
2022
Q1 		$301M Buy
1,675,414
+710,668
+74% +$135M 0.05% 314
2021
Q4 		$208M Buy
964,746
+962,136
+36,863% +$189M 0.03% 432
2021
Q3 		$482K Buy
2,610
+924
+55% +$182K ﹤0.01% 1944
2021
Q2 		$302K Buy
+1,686
New +$321K ﹤0.01% 2026
2021
Q1 		– Sell
-4,683
Closed -$711K – 2187
2020
Q4 		$711K Buy
+4,683
New +$615K ﹤0.01% 1664
2020
Q1 		– Sell
-11,272
Closed -$993K – 2053
2019
Q4 		$993K Buy
11,272
+8,091
+254% +$712K ﹤0.01% 1710
2019
Q3 		$253K Sell
3,181
-730
-19% -$58.8K ﹤0.01% 1968
2019
Q2 		$305K Buy
3,911
+67
+2% +$6.26K ﹤0.01% 1975
2019
Q1 		$451K Buy
3,844
+497
+15% +$57.9K ﹤0.01% 1913
2018
Q4 		$364K Sell
3,347
-6,614
-66% -$767K ﹤0.01% 1950
2018
Q3 		$1.27M Buy
9,961
+659
+7% +$81.5K ﹤0.01% 1820
2018
Q2 		$1.05M Sell
9,302
-73
-0.8% -$8.02K ﹤0.01% 1876
2018
Q1 		$1.05M Buy
9,375
+106
+1% +$13.5K ﹤0.01% 1892
2017
Q4 		$1.37M Sell
9,269
-518
-5% -$65.8K ﹤0.01% 1829
2017
Q3 		$1.15M Buy
9,787
+519
+6% +$66.3K ﹤0.01% 1849
2017
Q2 		$1.2M Buy
9,268
+978
+12% +$122K ﹤0.01% 1840
2017
Q1 		$1.12M Sell
8,290
-1,213
-13% -$184K ﹤0.01% 1897
2016
Q4 		$1.36M Buy
9,503
+1
+0% +$128 ﹤0.01% 1794
2016
Q3 		$1.12M Sell
9,502
-39
-0.4% -$4.69K ﹤0.01% 1817
2016
Q2 		$1.01M Sell
9,541
-6,105
-39% -$681K ﹤0.01% 1777
2016
Q1 		$1.74M Buy
15,646
+7,278
+87% +$921K ﹤0.01% 1642
2015
Q4 		$1.31M Sell
8,368
-1,029
-11% -$150K ﹤0.01% 1753
2015
Q3 		$1.23M Sell
9,397
-109,100
-92% -$17.5M ﹤0.01% 1787
2015
Q2 		$20.6M Buy
118,497
+10,148
+9% +$1.83M 0.01% 1011
2015
Q1 		$18.7M Buy
108,349
+94,730
+696% +$14.4M ﹤0.01% 1058
2014
Q4 		$1.76M Sell
13,619
-4,600
-25% -$593K ﹤0.01% 1720
2014
Q3 		$2.34M Buy
18,219
+220
+1% +$22.7K ﹤0.01% 1641
2014
Q2 		$1.59M Hold
17,999
– – ﹤0.01% 1722
2014
Q1 		$1.69M Sell
17,999
-1,238
-6% -$127K ﹤0.01% 1725
2013
Q4 		$2.17M Sell
19,237
-26,429
-58% -$2.38M ﹤0.01% 1683
2013
Q3 		$3.6M Sell
45,666
-1,291,146
-97% -$94.4M ﹤0.01% 1510
2013
Q2 		$88M Buy
+1,336,812
New +$86.1M 0.03% 510

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Wellington Management Group's UTHR Position: Q2 2026 in Review

Wellington Management Group reduced its United Therapeutics (UTHR) stake by 39% in Q2 2026, selling an estimated $499M and leaving 1,379,025 shares worth $747M. The position accounts for 0.13% of the portfolio, ranked #167.

Wellington Management Group first reported a position in UTHR in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.34B in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Wellington Management Group held 1,379,025 shares of United Therapeutics worth $747M as of Q2 2026.
  • Wellington Management Group sold 885,222 United Therapeutics shares in Q2 2026, an estimated $499M.
  • United Therapeutics made up 0.13% of Wellington Management Group's portfolio in Q2 2026, its #167 holding.
  • Wellington Management Group first reported a position in United Therapeutics in Q2 2013 and has held it in 49 quarters since.
  • Wellington Management Group's United Therapeutics position peaked at $1.34B in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.